These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 27468561)

  • 21. The value of fiberoptic bronchoscopy in culture-positive pulmonary tuberculosis patients whose pre-bronchoscopic sputum specimens were negative both for smear and PCR analyses.
    Tamura A; Shimada M; Matsui Y; Kawashima M; Suzuki J; Ariga H; Ohshima N; Masuda K; Matsui H; Nagai H; Nagayama N; Toyota E; Akagawa S; Hebisawa A
    Intern Med; 2010; 49(2):95-102. PubMed ID: 20075571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting.
    Theron G; Peter J; van Zyl-Smit R; Mishra H; Streicher E; Murray S; Dawson R; Whitelaw A; Hoelscher M; Sharma S; Pai M; Warren R; Dheda K
    Am J Respir Crit Care Med; 2011 Jul; 184(1):132-40. PubMed ID: 21493734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incomplete sputum smear microscopy monitoring among smear-positive tuberculosis patients in Uganda.
    Nakaggwa P; Odeke R; Kirenga BJ; Bloss E
    Int J Tuberc Lung Dis; 2016 May; 20(5):594-9. PubMed ID: 27084811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of hypoxia-inducible factor 1 (Hif-1) enhanced bactericidal effects of macrophages to Mycobacterium tuberculosis.
    Li Q; Xie Y; Cui Z; Huang H; Yang C; Yuan B; Shen P; Shi C
    Tuberculosis (Edinb); 2021 Jan; 126():102044. PubMed ID: 33383382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of time to positive and colony counting in an early bactericidal activity study of anti-tuberculosis treatment.
    Bark CM; Gitta P; Ogwang S; Nsereko M; Thiel BA; Boom WH; Eisenach KD; Joloba ML; Johnson JL
    Int J Tuberc Lung Dis; 2013 Nov; 17(11):1448-51. PubMed ID: 24125449
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of multidrug-resistant tuberculosis using MGIT™(TM) and MAS-PCR in Tripura, India.
    Majumdar T; Bhattacharya S; Barman D; Bhoumik P; Bir R
    Int J Tuberc Lung Dis; 2016 Feb; 20(2):166-9. PubMed ID: 26792467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between pulmonary tuberculosis and Type 2 diabetes in Sudanese patients.
    Ahmed M; Omer I; Osman SM; Ahmed-Abakur EH
    Int J Mycobacteriol; 2017; 6(1):97-101. PubMed ID: 28317813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical diagnostic performance of the simultaneous amplification and testing methods for detection of the Mycobacterium tuberculosis complex for smear-negative or sputum-scarce pulmonary tuberculosis in China.
    Fan L; Zhang Q; Cheng L; Liu Z; Ji X; Cui Z; Ju J; Xiao H
    Chin Med J (Engl); 2014; 127(10):1863-7. PubMed ID: 24824246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monitoring treatment of patients with pulmonary tuberculosis: can PCR be applied?
    Thomsen VO; Kok-Jensen A; Buser M; Philippi-Schulz S; Burkardt HJ
    J Clin Microbiol; 1999 Nov; 37(11):3601-7. PubMed ID: 10523560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhalable poly(lactic-co-glycolic acid) (PLGA) microparticles encapsulating all-trans-Retinoic acid (ATRA) as a host-directed, adjunctive treatment for Mycobacterium tuberculosis infection.
    O'Connor G; Krishnan N; Fagan-Murphy A; Cassidy J; O'Leary S; Robertson BD; Keane J; O'Sullivan MP; Cryan SA
    Eur J Pharm Biopharm; 2019 Jan; 134():153-165. PubMed ID: 30385419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Host blood RNA signatures predict the outcome of tuberculosis treatment.
    Thompson EG; Du Y; Malherbe ST; Shankar S; Braun J; Valvo J; Ronacher K; Tromp G; Tabb DL; Alland D; Shenai S; Via LE; Warwick J; Aderem A; Scriba TJ; Winter J; Walzl G; Zak DE;
    Tuberculosis (Edinb); 2017 Dec; 107():48-58. PubMed ID: 29050771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of messenger RNA (mRNA) of Mycobacterium tuberculosis as a marker of cure in patients with pulmonary tuberculosis.
    Montenegro RA; Guarines KM; Montenegro LM; Lira LA; Falcão J; Melo FL; Santos FC; Nascimento AL; Zuzarte MS; Leite RC; Schindler HC
    J Appl Microbiol; 2014 Jul; 117(1):266-72. PubMed ID: 24684542
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic performance of genoType
    Idrees F; Irfan M; Jabeen K; Farooqi J; Hasan R
    Int J Mycobacteriol; 2017; 6(2):122-126. PubMed ID: 28559511
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of contact tracing completion and outcomes in tuberculosis: a 21-year retrospective cohort study.
    Saunders MJ; Koh GC; Small AD; Dedicoat M
    Int J Tuberc Lung Dis; 2014 Jun; 18(6):640-6. PubMed ID: 24903932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk and outcome of multidrug-resistant tuberculosis: vitamin D receptor polymorphisms and serum 25(OH)D.
    Rathored J; Sharma SK; Singh B; Banavaliker JN; Sreenivas V; Srivastava AK; Mohan A; Sachan A; Harinarayan CV; Goswami R
    Int J Tuberc Lung Dis; 2012 Nov; 16(11):1522-8. PubMed ID: 22990231
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the Xpert MTB/RIF assay for the diagnosis of smear-negative pulmonary and extrapulmonary tuberculosis in Madagascar.
    Rakotoarivelo R; Ambrosioni J; Rasolofo V; Raberahona M; Rakotosamimanana N; Andrianasolo R; Ramanampamonjy R; Tiaray M; Razafimahefa J; Rakotoson J; Randria M; Bonnet F; Calmy A;
    Int J Infect Dis; 2018 Apr; 69():20-25. PubMed ID: 29408360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TB-PCR and drug resistance pattern in BALF in smear-negative active pulmonary TB.
    Chavalertsakul K; Boonsarngsuk V; Saengsri S; Santanirand P
    Int J Tuberc Lung Dis; 2017 Dec; 21(12):1294-1299. PubMed ID: 28992819
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic factors of treatment among patients with multidrug-resistant tuberculosis in Egypt.
    Gadallah MA; Mokhtar A; Rady M; El-Moghazy E; Fawzy M; Kandil SK
    J Formos Med Assoc; 2016 Nov; 115(11):997-1003. PubMed ID: 26696497
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Time to sputum conversion in smear positive pulmonary TB patients on category I DOTS and factors delaying it.
    Parikh R; Nataraj G; Kanade S; Khatri V; Mehta P
    J Assoc Physicians India; 2012 Aug; 60():22-6. PubMed ID: 23405517
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of quantitative polymerase chain reaction, acid fast bacilli smear, and culture results in patients receiving therapy for pulmonary tuberculosis.
    Afghani B; Lieberman JM; Duke MB; Stutman HR
    Diagn Microbiol Infect Dis; 1997 Oct; 29(2):73-9. PubMed ID: 9368082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.